These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 14981009)

  • 21. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
    Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
    Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of usefulness of left ventricular diastolic versus systolic function as a predictor of outcome following primary percutaneous coronary angioplasty for acute myocardial infarction.
    Naqvi TZ; Padmanabhan S; Rafii F; Hyuhn HK; Mirocha J
    Am J Cardiol; 2006 Jan; 97(2):160-6. PubMed ID: 16442355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
    Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
    Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus.
    McCormick LM; Heck PM; Ring LS; Kydd AC; Clarke SJ; Hoole SP; Dutka DP
    Cardiovasc Diabetol; 2015 Aug; 14():102. PubMed ID: 26253538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention.
    O'Neill WW; Martin JL; Dixon SR; Bartorelli AL; Trabattoni D; Oemrawsingh PV; Atsma DE; Chang M; Marquardt W; Oh JK; Krucoff MW; Gibbons RJ; Spears JR;
    J Am Coll Cardiol; 2007 Jul; 50(5):397-405. PubMed ID: 17662390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes.
    Nauck MA
    Horm Metab Res; 2004; 36(11-12):852-8. PubMed ID: 15655719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of left ventricular dysfunction in patients with first acute anterior myocardial infarction undergoing primary angioplasty.
    Hamdan A; Kornowski R; Solodky A; Fuchs S; Battler A; Assali AR
    Isr Med Assoc J; 2006 Aug; 8(8):532-5. PubMed ID: 16958241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
    Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
    Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Predictive factors of deteriorating left ventricular function after direct percutaneous coronary intervention for acute anterior myocardial infarction].
    Katayama T; Nakashima H; Furudono S; Honda Y; Suzuki S; Yano K
    J Cardiol; 2004 May; 43(5):205-13. PubMed ID: 15188607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction.
    De Luca L; Proietti P; Celotto A; Bucciarelli-Ducci C; Benedetti G; Di Roma A; Sardella G; Genuini I; Fedele F
    Am Heart J; 2005 Sep; 150(3):563-8. PubMed ID: 16169341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow cells for myocardial repair-a new therapeutic concept.
    Shah VK; Desai AJ; Vasvani JB; Desai MM; Shah BP; Lall TK; Mashru MR; Shalia KK; Tanavde V; Desai SS; Jankharia BJ
    Indian Heart J; 2007; 59(6):482-90. PubMed ID: 19151463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucagon-like peptide-1 (GLP-1) attenuates post-resuscitation myocardial microcirculatory dysfunction.
    Dokken BB; Hilwig WR; Teachey MK; Panchal RA; Hubner K; Allen D; Rogers DC; Kern KB
    Resuscitation; 2010 Jun; 81(6):755-60. PubMed ID: 20347207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of percutaneous coronary intervention on regional and global left ventricular function in patients with chronic total occlusions.
    Ermis C; Boz A; Tholakanahalli V; Yalcinkaya S; Semiz E; Sancaktar O; Benditt DG; Deger N
    Can J Cardiol; 2005 Mar; 21(3):275-80. PubMed ID: 15776117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction.
    Ndrepepa G; Mehilli J; Martinoff S; Schwaiger M; Schömig A; Kastrati A
    J Am Coll Cardiol; 2007 Jul; 50(2):149-56. PubMed ID: 17616299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics.
    Baks T; van Geuns RJ; Biagini E; Wielopolski P; Mollet NR; Cademartiri F; van der Giessen WJ; Krestin GP; Serruys PW; Duncker DJ; de Feyter PJ
    J Am Coll Cardiol; 2006 Jan; 47(1):40-4. PubMed ID: 16386662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of microvascular reperfusion on prognosis and left ventricular function in anterior wall myocardial infarction treated with primary angioplasty.
    Araszkiewicz A; Lesiak M; Grajek S; Prech M; Grygier M; Mularek-Kubzdela T; Cieslinski A
    Int J Cardiol; 2007 Jan; 114(2):183-7. PubMed ID: 16793152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy.
    Nikolaidis LA; Elahi D; Shen YT; Shannon RP
    Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2401-8. PubMed ID: 16024574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of glucagon-like peptide-1 agents on reperfusion injury for acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Huang M; Wei R; Wang Y; Su T; Li Q; Yang X; Chen X
    Ann Med; 2017 Nov; 49(7):552-561. PubMed ID: 28286967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracoronary infusion of encapsulated glucagon-like peptide-1-eluting mesenchymal stem cells preserves left ventricular function in a porcine model of acute myocardial infarction.
    de Jong R; van Hout GP; Houtgraaf JH; Kazemi K; Wallrapp C; Lewis A; Pasterkamp G; Hoefer IE; Duckers HJ
    Circ Cardiovasc Interv; 2014 Oct; 7(5):673-83. PubMed ID: 25294400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of liraglutide, a glucagon-like peptide-1 analog, on left ventricular remodeling assessed by cardiac magnetic resonance imaging in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Nozue T; Yamada M; Tsunoda T; Katoh H; Ito S; Iwaki T; Michishita I
    Heart Vessels; 2016 Aug; 31(8):1239-46. PubMed ID: 26293570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.